Ongoing research is focused on understanding the molecular and genetic basis of leiomyosarcoma to develop targeted therapies. Clinical trials are exploring the efficacy of novel drugs and combinations, as well as immunotherapy approaches. Advances in genomic sequencing and personalized medicine hold promise for more effective and tailored treatments.
